SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-027413
Filing Date
2013-05-09
Accepted
2013-05-09 16:08:16
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v342987_10q.htm 10-Q 354227
2 EXHIBIT 31.1 v342987_ex31-1.htm EX-31.1 9683
3 EXHIBIT 31.2 v342987_ex31-2.htm EX-31.2 9179
4 EXHIBIT 32.1 v342987_ex32-1.htm EX-32.1 3865
5 EXHIBIT 32.2 v342987_ex32-2.htm EX-32.2 3710
  Complete submission text file 0001144204-13-027413.txt   3470888

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT nvax-20130331.xml EX-101.INS 375991
7 XBRL TAXONOMY EXTENSION SCHEMA nvax-20130331.xsd EX-101.SCH 37945
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvax-20130331_cal.xml EX-101.CAL 48738
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvax-20130331_def.xml EX-101.DEF 103837
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvax-20130331_lab.xml EX-101.LAB 514040
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvax-20130331_pre.xml EX-101.PRE 231711
Mailing Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850
Business Address 9920 BELWARD CAMPUS DRIVE ROCKVILLE MD 20850 240-268-2000
NOVAVAX INC (Filer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-26770 | Film No.: 13828715
SIC: 2836 Biological Products, (No Diagnostic Substances)